• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CASP8-652 6N 插入/缺失启动子多态性与肾细胞癌风险和转移相关。

The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.

机构信息

Departments of Urology and Clinical Pathology (AH), Medical University of Vienna, Vienna, Austria.

出版信息

J Urol. 2013 Aug;190(2):717-22. doi: 10.1016/j.juro.2013.01.008. Epub 2013 Jan 9.

DOI:10.1016/j.juro.2013.01.008
PMID:23313206
Abstract

PURPOSE

Caspase-8 is a key regulator of apoptosis. Its cancer cell antigen induced cell death activity is strongly impacted by the insertion/deletion promoter polymorphism CASP8 -652 6N ins/del (rs3834129). We studied the association of this polymorphism with renal cell carcinoma risk and pathology.

MATERIALS AND METHODS

In this hospital based case-control study 500 Austrian patients were genotyped, including 250 with renal cell carcinoma, and 250 age and gender matched healthy controls. Polymerase chain reaction amplified genomic DNA was evaluated by restriction fragment length polymorphism analysis and automatic sequencing. We assessed associations with renal cell carcinoma risk and pathological factors, and performed a meta-analysis of the literature.

RESULTS

The CASP8 -652 6N ins/del polymorphism was significantly linked to renal cell carcinoma (chi-square for trend = 9.50, p = 0.002). Compared with ins/ins, del/del was associated with a 57% decreased risk of the disease (OR 0.43, 95% CI 0.26-0.73, p = 0.002). Furthermore, del/del was associated with a lower risk of distant metastases (p <0.05) but not with T stage, N stage or grade. On meta-analysis the CASP8 -652 6N ins/del polymorphism was associated with renal cell carcinoma risk (p <0.001).

CONCLUSIONS

The del/del genotype of the CASP8 -652 6N ins/del promoter polymorphism decreases the overall risk of renal cell carcinoma. It may be associated with a decreased risk of metastasis. Larger studies are warranted to validate our findings.

摘要

目的

Caspase-8 是细胞凋亡的关键调节因子。其癌细胞抗原诱导的细胞死亡活性受到插入/缺失启动子多态性 CASP8 -652 6N ins/del(rs3834129)的强烈影响。我们研究了这种多态性与肾细胞癌风险和病理学的关系。

材料和方法

在这项基于医院的病例对照研究中,对 500 名奥地利患者进行了基因分型,包括 250 名肾细胞癌患者和 250 名年龄和性别匹配的健康对照者。通过聚合酶链反应扩增基因组 DNA,并用限制性片段长度多态性分析和自动测序进行评估。我们评估了与肾细胞癌风险和病理因素的关联,并对文献进行了荟萃分析。

结果

Caspase-8 -652 6N ins/del 多态性与肾细胞癌显著相关(趋势 χ2 = 9.50,p = 0.002)。与 ins/ins 相比,del/del 与疾病风险降低 57%相关(OR 0.43,95%CI 0.26-0.73,p = 0.002)。此外,del/del 与远处转移风险降低相关(p <0.05),但与 T 分期、N 分期或分级无关。荟萃分析显示,Caspase-8 -652 6N ins/del 多态性与肾细胞癌风险相关(p <0.001)。

结论

Caspase-8 -652 6N ins/del 启动子多态性的 del/del 基因型降低了肾细胞癌的总体风险。它可能与转移风险降低有关。需要更大的研究来验证我们的发现。

相似文献

1
The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.CASP8-652 6N 插入/缺失启动子多态性与肾细胞癌风险和转移相关。
J Urol. 2013 Aug;190(2):717-22. doi: 10.1016/j.juro.2013.01.008. Epub 2013 Jan 9.
2
CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.CASP8-652 6Ndel 多态性与癌症风险:50112 例病例对照研究的荟萃分析。
Mutagenesis. 2012 Sep;27(5):559-66. doi: 10.1093/mutage/ges019. Epub 2012 Apr 18.
3
Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.用于检测乳腺癌中 caspase-8-6526Nins/del 启动子多态性(rs3834129)的双向 PCR 等位基因特异性扩增(bi-PASA)。
Gene. 2012 Aug 15;505(1):176-9. doi: 10.1016/j.gene.2012.05.043. Epub 2012 Jun 1.
4
CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.CASP8 启动子多态性与高危型 HPV 类型和异常细胞学改变有关,但与宫颈癌无关。
J Med Virol. 2011 Apr;83(4):630-6. doi: 10.1002/jmv.22009.
5
The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.CASP8 启动子区域的六核苷酸缺失/插入变体与头颈部鳞状细胞癌的风险呈负相关。
Cancer Prev Res (Phila). 2010 Feb;3(2):246-53. doi: 10.1158/1940-6207.CAPR-08-0228. Epub 2010 Jan 19.
6
The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.蛋白酶激活受体 1 基因变异 IVSn-14A>T 与肾细胞癌的远处转移和癌症特异性生存相关。
J Urol. 2013 Oct;190(4):1392-7. doi: 10.1016/j.juro.2013.03.041. Epub 2013 Mar 19.
7
Functional variants in cell death pathway genes and risk of pancreatic cancer.细胞死亡通路基因中的功能性变异与胰腺癌风险
Clin Cancer Res. 2008 May 15;14(10):3230-6. doi: 10.1158/1078-0432.CCR-08-0177.
8
A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.NFKB1基因启动子区域的功能性插入/缺失多态性(-94 ins/del ATTG)与肾细胞癌风险相关。
Urol Int. 2013;91(2):206-12. doi: 10.1159/000345630. Epub 2012 Dec 29.
9
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with risk of coal workers' pneumoconiosis.胱天蛋白酶8(CASP8)启动子区域的一个六核苷酸插入缺失多态性与煤工尘肺的发病风险相关。
J Toxicol Environ Health A. 2009;72(11-12):712-6. doi: 10.1080/15287390902841102.
10
Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.细胞死亡通路基因的功能多态性与肾细胞癌风险。
Mol Carcinog. 2010 Sep;49(9):810-7. doi: 10.1002/mc.20656.

引用本文的文献

1
The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA).膀胱尿路上皮癌(BLCA)中细胞焦亡相关基因、患者预后与肿瘤浸润细胞的关系
Front Pharmacol. 2022 Jul 19;13:930951. doi: 10.3389/fphar.2022.930951. eCollection 2022.
2
Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy.肾细胞癌靶向治疗的细胞死亡相关分子和生物标志物
Cancer Cell Int. 2019 Aug 23;19:221. doi: 10.1186/s12935-019-0939-2. eCollection 2019.
3
Association of Caspase-8 Genotypes With Oral Cancer Risk in Taiwan.
台湾 Caspase-8 基因型与口腔癌风险的关联。
In Vivo. 2019 Jul-Aug;33(4):1151-1156. doi: 10.21873/invivo.11585.
4
A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk.半胱天冬酶-8 -652 6N缺失多态性与消化道癌症风险的荟萃分析。
J Biomed Res. 2019 Jun 4;33(3):173-180. doi: 10.7555/JBR.32.20160030.
5
Analysis of 12 variants in the development of gastric and colorectal cancers.分析 12 种变异与胃癌和结直肠癌的发展关系。
World J Gastroenterol. 2017 Dec 28;23(48):8533-8543. doi: 10.3748/wjg.v23.i48.8533.
6
-652 6N insertion/deletion polymorphism and overall cancer risk: evidence from 49 studies.-652 6N插入/缺失多态性与总体癌症风险:来自49项研究的证据。
Oncotarget. 2017 May 25;8(34):56780-56790. doi: 10.18632/oncotarget.18187. eCollection 2017 Aug 22.
7
CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population.CD146启动子多态性(rs3923594)与中国人群透明细胞肾细胞癌复发相关。
Dis Markers. 2017;2017:2543059. doi: 10.1155/2017/2543059. Epub 2017 May 24.
8
The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.癌症基因组的暗物质:调控元件、非编码区、剪接位点、非编码RNA及同义突变中的畸变
EMBO Mol Med. 2016 May 2;8(5):442-57. doi: 10.15252/emmm.201506055. Print 2016 May.
9
Variants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma.参与复杂基因相互作用的SCARB1和VDR变体可能与透明细胞肾细胞癌的遗传易感性有关。
Biomed Res Int. 2015;2015:860405. doi: 10.1155/2015/860405. Epub 2015 Apr 6.
10
MicroRNA related polymorphisms and breast cancer risk.微小RNA相关多态性与乳腺癌风险
PLoS One. 2014 Nov 12;9(11):e109973. doi: 10.1371/journal.pone.0109973. eCollection 2014.